Claudio Giuliano

Statistics

Publications

Citations

963

H-Index

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Urology Foundation

Foundation Center

IRBM Science Park

Institute of Molecular Biology and Pathology

Claudio Giuliano is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, viral hepatitis, and medicinal chemistry.

ORCID

Publications per year

2005–2023

Publications

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

Vincenzo Summa, Steven W. Ludmerer, John A. McCauley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 255 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +16

Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Steven J. Harper, John A. McCauley, Michael T. Rudd et al. · ACS Medicinal Chemistry Letters · 2012 · 201 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism

Pascale Baden, Maria Jose Perez J., Hariam Raji et al. · Nature Communications · 2023 · 87 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease

Claudio Giuliano, Miriam Francavilla, Gerardo Ongari et al. · International Journal of Molecular Sciences · 2021 · 67 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Phosphoramidate Prodrugs of 2′-<i>C</i>-Methylcytidine for Therapy of Hepatitis C Virus Infection

Cristina Gardelli, Barbara Attenni, Monica Donghi et al. · Journal of Medicinal Chemistry · 2009 · 54 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 14